Vaxxa AB (NGM:VAXXA)

Vaxxa AB Statistics

Total Valuation

Vaxxa AB has a market cap or net worth of SEK 30.18 million. The enterprise value is 22.35 million.

Market Cap	30.18M
Enterprise Value	22.35M

Important Dates

The last earnings date was Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Vaxxa AB has 43.37 million shares outstanding. The number of shares has increased by 7.25% in one year.

Current Share Class	43.37M
Shares Outstanding	43.37M
Shares Change (YoY)	+7.25%
Shares Change (QoQ)	+1.45%
Owned by Insiders (%)	3.41%
Owned by Institutions (%)	n/a
Float	41.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.44
PB Ratio	1.37
P/TBV Ratio	1.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.77
EV / Sales	0.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-16.13

Financial Position

The company has a current ratio of 6.83, with a Debt / Equity ratio of 0.01.

Current Ratio	6.83
Quick Ratio	6.53
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.22
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -14.58% and return on invested capital (ROIC) is -9.37%.

Return on Equity (ROE)	-14.58%
Return on Assets (ROA)	-8.17%
Return on Invested Capital (ROIC)	-9.37%
Return on Capital Employed (ROCE)	-13.60%
Revenue Per Employee	8.61M
Profits Per Employee	-359,625
Employee Count	8
Asset Turnover	2.96
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.73% in the last 52 weeks. The beta is 0.40, so Vaxxa AB's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-33.73%
50-Day Moving Average	0.85
200-Day Moving Average	1.03
Relative Strength Index (RSI)	41.80
Average Volume (20 Days)	62,079

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vaxxa AB had revenue of SEK 68.92 million and -2.88 million in losses. Loss per share was -0.07.

Revenue	68.92M
Gross Profit	-1.86M
Operating Income	-3.04M
Pretax Income	-2.88M
Net Income	-2.88M
EBITDA	-995,000
EBIT	-3.04M
Loss Per Share	-0.07

Balance Sheet

The company has 8.14 million in cash and 300,000 in debt, giving a net cash position of 7.84 million or 0.18 per share.

Cash & Cash Equivalents	8.14M
Total Debt	300,000
Net Cash	7.84M
Net Cash Per Share	0.18
Equity (Book Value)	22.08M
Book Value Per Share	0.51
Working Capital	10.20M

Cash Flow

In the last 12 months, operating cash flow was -2.32 million and capital expenditures 933,000, giving a free cash flow of -1.39 million.

Operating Cash Flow	-2.32M
Capital Expenditures	933,000
Free Cash Flow	-1.39M
FCF Per Share	-0.03

Margins

Gross margin is -2.70%, with operating and profit margins of -4.42% and -4.17%.

Gross Margin	-2.70%
Operating Margin	-4.42%
Pretax Margin	-4.17%
Profit Margin	-4.17%
EBITDA Margin	-1.44%
EBIT Margin	-4.42%
FCF Margin	n/a

Dividends & Yields

Vaxxa AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.25%
Shareholder Yield	n/a
Earnings Yield	-9.53%
FCF Yield	-4.59%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 14, 2024. It was a reverse split with a ratio of 0.01.

Last Split Date	Mar 14, 2024
Split Type	Reverse
Split Ratio	0.01

Scores

Vaxxa AB has an Altman Z-Score of 16.68 and a Piotroski F-Score of 3.

Altman Z-Score	16.68
Piotroski F-Score	3